Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

February 28, 2011

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Chole Timothy

2. Date of Event Requiring Statement (Month/Day/Year)
05/21/2024

3. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [RMTI]

(Last)

(First)

(Middle)

C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
SVP, CHIEF COMMERCIAL OFFICER

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

WIXOM, MI 48393

6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	33,330 ⁽¹⁾	D
Common Stock	25,665 ⁽²⁾ ⁽³⁾	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Non-Qualified Stock Options	⁽⁴⁾	12/16/2029	Common Stock	4,545	$ 24.2	D
Non-Qualified Stock Options	⁽⁵⁾	06/11/2030	Common Stock	13,636	$ 22.44	D
Non-Qualified Stock Options	⁽⁶⁾	05/03/2031	Common Stock	13,636	$ 10.38	D
Non-Qualified Stock Options	⁽⁷⁾	09/09/2032	Common Stock	60,000	$ 1.66	D
Non-Qualified Stock Options	⁽⁸⁾	03/17/2033	Common Stock	32,990	$ 1.37	D
Non-Qualified Stock Options	⁽⁹⁾	03/14/2034	Common Stock	47,190	$ 1.39	D

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Chole Timothy C/O ROCKWELL MEDICAL, INC. 30142 WIXOM ROAD WIXOM, MI 48393			SVP, CHIEF COMMERCIAL OFFICER

Signatures

/s/ Megan Timmins, Attorney-in-Fact for Timothy Chole		05/30/2024
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Restricted stock units fully vest on March 14, 2027, subject to the Reporting Person's continued service to the Issuer.
(2)	Restricted stock units fully vest on March 17, 2025, subject to the Reporting Person's continued service to the Issuer.
(3)	Includes 12,832 shares of unvested common stock.
(4)	Stock options vested in three equal installments on the first, second and third anniversaries of December 16, 2019.
(5)	Stock options vested in three equal installments on the first, second and third anniversaries of June 11, 2020.
(6)	Stock options vest in two equal installments on the second and fourth anniversaries of May 3, 2021, subject to the Reporting Person's continued service to the Issuer.
(7)	Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued service to the Issuer.
(8)	Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer.
(9)	Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer.
Remarks: Ex. 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.